Acumen Pharmaceuticals Inc. (NASDAQ: ABOS) presented research at the 18th Annual Clinical Trials on Alzheimer's Disease conference on December 1-4 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE